You are here

Advair

Novartis Smoker’s Cough Treatment Beats Glaxo’s Advair in Trial

Bloomberg Businessweek

Wed, 08/29/12 - 10:49 am

GSK and Theravance file next-generation Advair in USA, EU

Pharma Times, UK

Mon, 07/16/12 - 12:24 pm

Glaxo Executives Cited in Case Now Lead Sanofi, Actelion

Bloomberg Businessweek

Thu, 07/5/12 - 05:21 pm

Breathe Easy: Relovair Program Complete, Data Solid

Motley Fool

Thu, 03/29/12 - 12:02 pm

Theravance: A $1.5 Billion Company With An $8 Billion Product

Seeking Alpha

Wed, 02/22/12 - 05:47 pm

Glaxo Tests Cheaper Version of Advair for Emerging Markets

Bloomberg

Thu, 02/9/12 - 12:07 pm

emerging markets

Lipitor's $131B lifetime sales dwarf other megablockbusters

Fierce Pharma

Mon, 11/7/11 - 12:09 pm

Vectura gets new U.S. partner for copy of lung drug

Reuters

Wed, 08/3/11 - 11:10 am

As Advair Sales Erode, Benlysta Gets EMA Nod

Motley Fool

Fri, 07/15/11 - 01:02 am

Human Genome Sciences

GSK chief was right about tough-to-copy Advair

Fierce Pharma

Fri, 11/5/10 - 11:23 am

Teva Pharmaceuticals

Merck Breathes Life Into an Acquired Pipeline

Motley Fool

Sat, 06/26/10 - 09:22 am

FDA orders new warning labels on GlaxoSmithKline asthma drugs Serevent, Advair

Bizjournals.com

Thu, 06/3/10 - 09:40 am

Glaxo's Asthma Drug Looks Increasingly Bullet-Proof

Seeking Alpha

Sat, 03/20/10 - 11:34 am

Glaxo up as Novartis drops generic Advair in U.S.

Reuters

Thu, 03/18/10 - 10:12 am

GlaxoSmithKline reviewing FDA labelling proposals

Marketwatch

Fri, 02/19/10 - 09:15 am

Asthma drugs get stiff new warnings

Forbes

Thu, 02/18/10 - 08:47 pm

GSK's Advair up for dispute in Germany

Fierce Pharma

Thu, 02/18/10 - 10:59 am

Witty: No rivals coming for Advair

Fierce Pharma

Wed, 01/13/10 - 08:13 pm

GlaxoSmithKline cut at SocGen on threat to Advair

Marketwatch

Thu, 09/10/09 - 08:49 am

Irish court invalidates patent on Glaxo's top drug

Reuters

Fri, 06/26/09 - 11:03 am

Pages